Effect of psychological nursing interventions on effectiveness and quality of life in schizophrenia patients receiving modified electroconvulsive therapy
- PMID: 38899291
- PMCID: PMC11185346
- DOI: 10.12998/wjcc.v12.i16.2751
Effect of psychological nursing interventions on effectiveness and quality of life in schizophrenia patients receiving modified electroconvulsive therapy
Abstract
Background: Schizophrenia is a common and severe mental disorder characterized by severe thought disturbances, hallucinations, delusions, and emotional instability. For some patients, conventional treatment methods may not effectively alleviate symptoms, necessitating the use of alternative therapeutic approaches. Modified electroconvulsive therapy (MECT) is an effective treatment modality for schizophrenia, inducing anti-depressive and antipsychotic effects through the stimulation of brain electrical activity.
Aim: To explore the impact of psychological nursing intervention (PNI) before and after MECT on the efficacy and quality of life of patients with schizophrenia.
Methods: Eighty patients with schizophrenia who received MECT treatment from 2021 to 2023 were randomly divided into two groups: The intervention group (n = 40) and the control group (n = 40). The intervention group received PNI before and after MECT, while the control group received routine nursing care. The efficacy of MECT was evaluated by the Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression Scale (CGI) before and after the treatment. The quality of life was assessed by the Short Form 36 Health Survey (SF-36) after the treatment.
Resuits: The intervention group had significantly lower scores of PANSS and CGI than the control group after the treatment (P < 0.05). The intervention group also had significantly higher scores of SF-36 than the control group in all domains except physical functioning (P < 0.05).
Conclusion: PNI before and after MECT can improve the efficacy and quality of life of patients with schizophrenia. It is suggested that nurses should provide individualized and comprehensive psychological care for patients undergoing MECT to enhance their recovery and well-being.
Keywords: Efficacy; Modified electroconvulsive therapy; Positive and negative syndrome scale; Psychological nursing interventions; Quality of life; Schizophrenia.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Similar articles
-
Niacin skin flushing response in patients with schizophrenia: Associations with the efficacy of modified electroconvulsive therapy and clinical symptoms.J Psychiatr Res. 2025 Jun;186:226-234. doi: 10.1016/j.jpsychires.2025.04.025. Epub 2025 Apr 15. J Psychiatr Res. 2025. PMID: 40252363
-
Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS).Neuropsychiatr Dis Treat. 2025 Mar 5;21:491-501. doi: 10.2147/NDT.S497725. eCollection 2025. Neuropsychiatr Dis Treat. 2025. PMID: 40060028 Free PMC article. Clinical Trial.
-
Effects of modified electroconvulsive therapy on the cognitive function and blood parameters in female patients with schizophrenia.Int J Clin Exp Med. 2015 Jan 15;8(1):1349-55. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25785136 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Electroconvulsive therapy for treatment-resistant schizophrenia.Cochrane Database Syst Rev. 2019 Mar 19;3(3):CD011847. doi: 10.1002/14651858.CD011847.pub2. Cochrane Database Syst Rev. 2019. PMID: 30888709 Free PMC article.
References
-
- Carpenter WT Jr, Buchanan RW. Schizophrenia. N Engl J Med. 1994;330:681–690. - PubMed
-
- Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res. 2010;122:1–23. - PubMed
-
- Chong HY, Chaiyakunapruk N, D B C W, K K C L, Chiou CF. Global Economic Burden of Schizophrenia: A Systematic Review. Value Health. 2014;17:A767. - PubMed
-
- Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31–41. - PubMed
-
- Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, Lehman A, Tenhula WN, Calmes C, Pasillas RM, Peer J, Kreyenbuhl J Schizophrenia Patient Outcomes Research Team (PORT) The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36:48–70. - PMC - PubMed
LinkOut - more resources
Full Text Sources